Published in J Virol on November 28, 2016
How cells respond to interferons. Annu Rev Biochem (1998) 24.27
Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A (1998) 13.39
A diverse range of gene products are effectors of the type I interferon antiviral response. Nature (2011) 12.86
The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 7.88
Respiratory syncytial virus and parainfluenza virus. N Engl J Med (2001) 7.69
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
Cytoplasmic activation of ISGF3, the positive regulator of interferon-alpha-stimulated transcription, reconstituted in vitro. Genes Dev (1989) 5.09
IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 4.66
Pan-viral specificity of IFN-induced genes reveals new roles for cGAS in innate immunity. Nature (2013) 4.45
ISGF3, the transcriptional activator induced by interferon alpha, consists of multiple interacting polypeptide chains. Proc Natl Acad Sci U S A (1990) 4.11
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
Interferon-stimulated genes: a complex web of host defenses. Annu Rev Immunol (2014) 3.47
N protein of vesicular stomatitis virus selectively encapsidates leader RNA in vitro. Cell (1983) 3.46
Interferon-stimulated genes and their antiviral effector functions. Curr Opin Virol (2011) 3.44
The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol (2012) 3.17
Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. J Virol (2010) 3.10
Interaction of VSV leader RNA and nucleocapsid protein may control VSV genome replication. Cell (1981) 3.06
Interferon-induced proteins and the antiviral state. Adv Virus Res (1990) 2.84
Retinoic acid-inducible gene I mediates early antiviral response and Toll-like receptor 3 expression in respiratory syncytial virus-infected airway epithelial cells. J Virol (2006) 2.76
Virus factories: associations of cell organelles for viral replication and morphogenesis. Biol Cell (2005) 2.65
Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol (2007) 2.40
Paramyxovirus membrane fusion: lessons from the F and HN atomic structures. Virology (2006) 2.36
Distinct induction patterns and functions of two closely related interferon-inducible human genes, ISG54 and ISG56. J Biol Chem (2006) 2.15
Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol Cell (2007) 2.03
Interferons and viral infections. Biofactors (2009) 1.99
IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 1.86
Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-beta compared with IFN-alpha2. J Interferon Cytokine Res (2003) 1.82
Association of the parainfluenza virus fusion and hemagglutinin-neuraminidase glycoproteins on cell surfaces. J Virol (1997) 1.71
Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma. Proc Natl Acad Sci U S A (1988) 1.71
Formation of STAT1-STAT2 heterodimers and their role in the activation of IRF-1 gene transcription by interferon-alpha. J Biol Chem (1996) 1.65
Mouse p56 blocks a distinct function of eukaryotic initiation factor 3 in translation initiation. J Biol Chem (2004) 1.63
Interferon inhibits viral protein synthesis in L cells infected with vaccinia virus. Nature (1972) 1.63
2'-O methylation of the viral mRNA cap by West Nile virus evades ifit1-dependent and -independent mechanisms of host restriction in vivo. PLoS Pathog (2012) 1.62
Gene expression profiling of the cellular transcriptional network regulated by alpha/beta interferon and its partial attenuation by the hepatitis C virus nonstructural 5A protein. J Virol (2003) 1.56
Gene expression of nonsegmented negative strand RNA viruses. Pharmacol Ther (1991) 1.53
Mouse STAT2 restricts early dengue virus replication. Cell Host Microbe (2010) 1.53
IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol (2013) 1.52
ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol (2011) 1.50
Inhibitors of respiratory syncytial virus replication target cotranscriptional mRNA guanylylation by viral RNA-dependent RNA polymerase. J Virol (2005) 1.48
Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: Evidence that NBs are sites of viral transcription and replication. J Virol (2009) 1.43
Paramyxovirus mediated cell fusion requires co-expression of both the fusion and hemagglutinin-neuraminidase glycoproteins. Virus Res (1994) 1.42
IFITM3 restricts influenza A virus entry by blocking the formation of fusion pores following virus-endosome hemifusion. PLoS Pathog (2014) 1.42
IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol (2013) 1.39
Tryptophan catabolism and regulation of adaptive immunity. J Immunol (2003) 1.36
The role of protein kinase R in the interferon response. J Interferon Cytokine Res (2010) 1.35
Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways. J Virol (2009) 1.34
Respiratory syncytial virus strain A2 is resistant to the antiviral effects of type I interferons and human MxA. Virology (1999) 1.32
Ribose 2'-O methylation of the vesicular stomatitis virus mRNA cap precedes and facilitates subsequent guanine-N-7 methylation by the large polymerase protein. J Virol (2009) 1.27
Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity (2014) 1.25
Identification of an endocytic signal essential for the antiviral action of IFITM3. Cell Microbiol (2014) 1.23
Interferon-stimulated genes: roles in viral pathogenesis. Curr Opin Virol (2014) 1.22
Activation of paramyxovirus membrane fusion and virus entry. Curr Opin Virol (2014) 1.16
Viperin: a multifunctional, interferon-inducible protein that regulates virus replication. Cell Host Microbe (2011) 1.14
Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. PLoS Pathog (2013) 1.14
Influenza virus partially counteracts restriction imposed by tetherin/BST-2. J Biol Chem (2012) 1.13
Human respiratory syncytial virus nucleoprotein and inclusion bodies antagonize the innate immune response mediated by MDA5 and MAVS. J Virol (2012) 1.13
Mechanism of fusion triggering by human parainfluenza virus type III: communication between viral glycoproteins during entry. J Biol Chem (2011) 1.11
Newcastle disease virus mRNA lacks 2'-O-methylated nucleotides. Nature (1976) 1.10
IFITM-Family Proteins: The Cell's First Line of Antiviral Defense. Annu Rev Virol (2014) 1.08
Indoleamine 2,3-dioxygenase mediates the antiviral effect of gamma interferon against hepatitis B virus in human hepatocyte-derived cells. J Virol (2010) 1.08
Ifit1 inhibits Japanese encephalitis virus replication through binding to 5' capped 2'-O unmethylated RNA. J Virol (2013) 1.07
Inhibition of translation by IFIT family members is determined by their ability to interact selectively with the 5'-terminal regions of cap0-, cap1- and 5'ppp- mRNAs. Nucleic Acids Res (2013) 1.07
Interferon-induced Ifit proteins: their role in viral pathogenesis. J Virol (2014) 1.07
Inhibition of human herpes simplex virus type 2 by interferon gamma and tumor necrosis factor alpha is mediated by indoleamine 2,3-dioxygenase. Microbes Infect (2004) 1.06
The structure of the 5' terminal cap of the respiratory syncytial virus mRNA. J Gen Virol (1993) 1.06
Envelope protein dynamics in paramyxovirus entry. MBio (2013) 1.03
Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon. J Virol (2005) 1.03
Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. J Virol (2008) 0.98
The inhibitory action of P56 on select functions of E1 mediates interferon's effect on human papillomavirus DNA replication. J Virol (2010) 0.98
An unconventional pathway of mRNA cap formation by vesiculoviruses. Virus Res (2011) 0.94
ISG56/IFIT1 is primarily responsible for interferon-induced changes to patterns of parainfluenza virus type 5 transcription and protein synthesis. J Gen Virol (2012) 0.93
The role of viperin in the innate antiviral response. J Mol Biol (2013) 0.93
Current status of vaccines for parainfluenza virus infections. Pediatr Infect Dis J (2008) 0.92
New Insights into IDO Biology in Bacterial and Viral Infections. Front Immunol (2014) 0.92
IFITs: Emerging Roles as Key Anti-Viral Proteins. Front Immunol (2014) 0.88
Protein kinase R and the inflammasome. J Interferon Cytokine Res (2014) 0.85
Replication of respiratory syncytial virus is inhibited by the host defense molecule viperin. J Innate Immun (2012) 0.85
No Love Lost Between Viruses and Interferons. Annu Rev Virol (2015) 0.84
Viperin protein expression inhibits the late stage of respiratory syncytial virus morphogenesis. Antiviral Res (2014) 0.82
Indoleamine 2,3-dioxygenase mediates immune-independent human tumor cell resistance to olaparib, gamma radiation, and cisplatin. Oncotarget (2014) 0.82
Indoleamine 2,3-dioxygenase (IDO) activity during the primary immune response to influenza infection modifies the memory T cell response to influenza challenge. Viral Immunol (2014) 0.80
Respiratory syncytial virus induces indoleamine 2,3-dioxygenase activity: a potential novel role in the development of allergic disease. Clin Exp Allergy (2015) 0.80
To translate, or not to translate: viral and host mRNA regulation by interferon-stimulated genes. Trends Cell Biol (2015) 0.80
Human respiratory syncytial virus infection is inhibited by IFN-induced transmembrane proteins. J Gen Virol (2014) 0.79
Cytosolic Innate Immune Sensing and Signaling upon Infection. Front Microbiol (2016) 0.79
What Really Rigs Up RIG-I? J Innate Immun (2016) 0.79
Is the expression of deoxynucleoside kinases and 5'-nucleotidases in animal tissues related to the biological effects of nucleoside analogs? Curr Med Chem (2013) 0.76